FDA Inspection
Sunrise Pharmaceutical, Inc.Sunrise Pharmaceutical, Inc. – FDA Inspection, Jun 22, 2017
Record Details
This FDA Inspection record concerns Sunrise Pharmaceutical, Inc., with an inspection on June 22, 2017, issued by the New Jersey District Office, covering human drugs.
View Company Profile
ID · eee48849-d4cd-405e-afab-cb1952d81c15
Inspection Facts
- Inspection number
- 1016794
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Sunrise Pharmaceutical, Inc.
8| Date | Classification | Office | Project area |
|---|---|---|---|
| March 31, 2026 | Not classified | New Jersey District Office | Drug Quality Assurance |
| January 27, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 18, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 6, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 8, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Sunrise Pharmaceutical, Inc.
- FDA Inspection 1310416 - 2026-03-31
- FDA Inspection 1198356 - 2023-01-27
- FDA Inspection 1038016 - 2018-01-18
- FDA Inspection 1013086 - 2017-04-06
- FDA Inspection 861922 - 2014-01-08
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.